NextCell Pharma AB banner
N

NextCell Pharma AB
STO:NXTCL

Watchlist Manager
NextCell Pharma AB
STO:NXTCL
Watchlist
Price: 1.436 SEK 1.13% Market Closed
Market Cap: kr160m

NextCell Pharma AB
Investor Relations

NextCell Pharma AB engages in the development of stem cell products. The company is headquartered in Huddinge, Stockholm. The company went IPO on 2017-07-13. The firm is focusing on research and development of stem cell therapies and is also running a tissue establishment and biobank, classified as healthcare provider. NextCell's business concept is to develop and commercialize mesenchymal stem cell products based on the Company's proprietary selection algorithm, primarily for the treatment of autoimmune diabetes, as well as other types of autoimmune diseases.

Show more
Loading
NXTCL
OMX Stockholm 30
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Mathias Svahn Ph.D.
Founder & CEO
No Bio Available
Mr. Patrik Fagerholm
Chief Financial Officer
No Bio Available
Mr. Lindsay Davies
Chief Scientific Officer
No Bio Available
Mr. Edvard Smith
Medical Director & Director
No Bio Available
Sofie Falk Jansson
Head of Cellaviva
No Bio Available
Ms. Sofia Sisay
Head of Clinical Trials
No Bio Available

Contacts

Address
STOCKHOLM
Huddinge
Karolinska Institutet Science Park, Halsovagen 7
Contacts